ADVANTAN CREAM

Indications

Approved Uses

Steroid-responsive inflammatory dermatoses such as atopic dermatitis (eczema) and contact dermatitis/eczema; may be used for other corticosteroid-responsive eczematous dermatoses per local labeling; psoriasis may be treated when steroid-responsive and localized (not for extensive plaque disease without specialist direction).

Off-Label Uses

Other steroid-responsive inflammatory dermatoses such as nummular eczema and dyshidrotic eczema; prurigo nodularis may be treated as a steroid-responsive condition (often as part of specialist care).

Dosage & Administration

Dosing by Condition

For steroid-responsive eczema/dermatitis: apply a thin layer once daily; typical course is short (often 1-2 weeks) and continued until control, then step down; for psoriasis (localized, steroid-responsive): apply once daily with similar short courses and specialist oversight for longer use or sensitive sites.

Initial Dose

Apply a thin layer to the affected skin area once daily

Maintenance Dose

Once daily application; reduce frequency as condition improves

Maximum Dose

Apply once daily; do not use continuously for more than 12 weeks in adults and 4 weeks in children (unless directed by a specialist).

Children's Dosage

Children 4 months and older: Apply thin layer once daily to affected area; maximum treatment duration 4 weeks; avoid application to face, skin folds, and large body surface areas; not approved under 4 months of age

Dose Adjustment Notes

Use the minimum effective amount for the shortest duration; once control is achieved, step down by reducing frequency (e.g., alternate-day or 2 days/week proactive maintenance) and/or switch to a lower-potency steroid or emollient-only regimen; if excessive dryness occurs, consider switching from cream to a more lipid-rich vehicle (ointment) as clinically appropriate.

How to Take

Apply a thin layer to the affected skin once daily and rub in gently; wash hands after use (unless treating hands); avoid eyes, mouth and mucous membranes; for external use only; do not use under occlusive dressings/bandages unless directed by a clinician.

Side Effects

Common Side Effects

Application-site burning/stinging, pruritus, erythema/irritation and dryness; with prolonged or extensive use: skin atrophy, striae, telangiectasia, folliculitis/acneiform eruptions, hypopigmentation, and secondary infection.

Side Effect Frequency

Common: application-site burning/stinging, pruritus (and sometimes dryness/erythema). Uncommon: folliculitis, rash/irritation, contact dermatitis, vesicles. Rare: skin atrophy, telangiectasia, striae; very rare/systemic with extensive/occlusive/prolonged use: HPA-axis suppression and secondary infection.

Safety & Warnings

Contraindications

Hypersensitivity to methylprednisolone aceponate/excipients; tuberculous or syphilitic skin processes; viral skin infections in the treatment area (e.g., herpes simplex, varicella); rosacea; perioral dermatitis; acne vulgaris; skin reactions to vaccinations at the treatment site.

Warnings & Precautions

Avoid eyes/mucosa and periocular use; avoid large areas, prolonged use, and occlusion unless directed; use caution on face/flexures/groin; treat coexisting bacterial/fungal infection appropriately and reassess if infection develops; monitor children closely due to higher absorption risk.

Age Restriction

Not recommended for infants under 4 months of age.

Driving Warning

Safe

Drug Interactions

Food Interaction

No known food interactions (not applicable for topical administration).

Special Populations

Children

Children 4 months and older: Apply thin layer once daily to affected area; maximum treatment duration 4 weeks; avoid application to face, skin folds, and large body surface areas; not approved under 4 months of age

Elderly

Standard adult dosing; use with caution as elderly skin may be more susceptible to atrophy with prolonged use

Liver Impairment

No adjustment needed

Storage & Patient Advice

Stopping the Medicine

For short courses, stop when controlled; after prolonged/large-area use, taper by reducing frequency/potency to minimize rebound dermatitis.

Patient Counseling

Apply a thin layer to the affected skin once daily (or as prescribed) and rub in gently; use the smallest amount for the shortest duration needed. For external use only-avoid eyes, mouth, and mucous membranes; wash hands after application (unless treating hands). Do not use on the face, groin, or axillae, on broken/infected skin, or under occlusive dressings/diapers unless specifically directed. Stop and seek medical advice if irritation occurs, the condition worsens, or signs of infection develop; do not use longer than prescribed (children require shorter courses).

Monitoring Requirements

No routine laboratory monitoring for short courses; clinically monitor for local adverse effects (atrophy, striae, telangiectasia, perioral dermatitis/rosacea flare), secondary infection, and-if prolonged, large-area, occlusive use, or pediatric use-signs of systemic corticosteroid effects/HPA-axis suppression and growth in children.

Pharmacology

Mechanism of Action

Topical glucocorticoid: binds intracellular glucocorticoid receptors to alter gene transcription, inducing lipocortin/macrocortin and inhibiting phospholipase A2, reducing arachidonic-acid-derived mediators (prostaglandins/leukotrienes) and cytokine-driven inflammation, producing anti-inflammatory, antipruritic and vasoconstrictive effects.

Onset of Action

Anti-inflammatory/vasoconstrictive effect begins within hours; symptomatic relief (itch/redness) often within 12-24 hours; lesion improvement typically within 3-7 days.

Duration of Effect

Approximately 12-24 hours per application (supports once-daily use); clinical benefit is maintained with continued daily use.

Bioavailability

Systemic bioavailability is low; percutaneous absorption is typically minimal (generally <1-3% on intact/inflamed skin) but can increase with damaged skin, large surface area, prolonged use, or occlusion.

Excretion

Primarily renal excretion of metabolites (urine) for the systemically absorbed fraction.

Product Information

Available Dosage Forms

Cream, Ointment, Fatty Ointment, Lotion/Milk, Solution.

Composition per Dose

Each gram of cream: 1 mg methylprednisolone aceponate (0.1%) in a cream base

OTC Alternatives

Hydrocortisone 0.5-1% topical (where available OTC) for mild dermatitis; regular emollients/moisturizers as first-line supportive therapy for xerosis/eczema symptoms.

Skin Condition

Eczema, Psoriasis

Steroid Potency

Potent

Legal Disclaimer - Al Mujtama Pharmacy

The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.

Al Mujtama Pharmacy assumes no legal or medical liability for:

• Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
• Any discrepancy between the information provided and the product's package insert or SFDA guidelines
• Any misuse of medication resulting from personal interpretation of the content displayed

Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.

By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.

Your health is a trust - always consult your doctor first.